Consumer Healthcare Market to record USD 123.78 Bn growth; North America to have a significant market share -- Technavio

News provided by

Oct 07, 2022, 18:45 ET

NEW YORK, Oct. 7, 2022 /PRNewswire/ -- The global consumer healthcare market size is expected to grow by USD 123.78 billion, accelerating at a CAGR of 5.66% between 2021 and 2026. According to the report, the market structure is fragmented due to the presence of several large and small vendors. The vendors in the market are adopting various strategies such as new product launches and strategic alliances to remain competitive and gain an edge over their rivals. Get detailed insights into the vendor landscape, successful strategies adopted by vendors, key product launches, and more by purchasing our full report. Download Sample PDF Report Before Purchasing

Technavio has announced its latest market research report titled Global Consumer Healthcare Market 2022-2026

The report identifies Abbott Laboratories, Amway Corp., BASF SE, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Chr Hansen Holding AS, Danone SA, Eisai Co. Ltd., Genomma Lab Internacional SAB de CV, Glanbia Plc, GlaxoSmithKline Plc, Herbalife Nutrition Ltd., Himalaya Global Holdings Ltd., Johnson and Johnson, Kellogg Co., Koninklijke DSM NV, Merck KGaA, Nestle SA, NUTRITION ET SANTE, Pfizer Inc., Reckitt Benckiser Group PLC, and Sanofi as major market participants. Although increasing awareness about lifestyle diseases will offer immense growth opportunities, intense competition will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Consumer Healthcare Market 2022-2026: Segmentation

The global consumer healthcare market is segmented as below:

Product

OTC Pharmaceuticals
Dietary Supplements

The market growth in the OTC pharmaceuticals segment will be significant over the forecast period. The segment is driven by the easy availability of OTC pharmaceuticals in pharmacies, hypermarkets, supermarkets, or other distribution channels. Also, the switch from prescription to OTC drugs and increased government reforms and support in the form of investments in the pharmaceutical sector are contributing to the growth of the segment.

Geography

North America
Asia
Europe
Rest Of World (ROW)

33% of the market growth will come from North America during the forecast period. Factors such as the surge in the number of skin diseases, the rapid technological advances in the pharmaceutical sector, and the growth of the geriatric population are driving the growth of the regional market. Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our consumer healthcare market report covers the following areas:

Consumer Healthcare Market 2022-2026: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the consumer healthcare market, including some of the dominant vendors. Backed with competitive intelligence and benchmarking, our research report on the consumer healthcare market is designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

Consumer Healthcare Market 2022-2026: Key Highlights

CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will assist consumer healthcare market growth during the next five years
Estimation of the consumer healthcare market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the consumer healthcare market
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of consumer healthcare market vendors

Related Reports:

Consumer Healthcare Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 5.66%
Market growth 2022-2026	USD 123.78 billion
Market structure	Fragmented
YoY growth (%)	5.13
Regional analysis	North America, Asia, Europe, and Rest of World (ROW)
Performing market contribution	North America at 33%
Key consumer countries	US, Canada, UK, Germany, and China
Competitive landscape	Leading companies, competitive strategies, consumer engagement scope
Companies profiled	Abbott Laboratories, Amway Corp., BASF SE, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Chr Hansen Holding AS, Danone SA, Eisai Co. Ltd., Genomma Lab Internacional SAB de CV, Glanbia Plc, GlaxoSmithKline Plc, Herbalife Nutrition Ltd., Himalaya Global Holdings Ltd., Johnson and Johnson, Kellogg Co., Koninklijke DSM NV, Merck KGaA, Nestle SA, NUTRITION ET SANTE, Pfizer Inc., Reckitt Benckiser Group PLC, and Sanofi
Market Dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table Of Contents:

1 Executive Summary

1.1 Market overview

Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
Exhibit 06: Executive Summary – Chart on Incremental Growth
Exhibit 07: Executive Summary – Data Table on Incremental Growth
Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem

Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition

Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis

Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary

Exhibit 17: Five forces analysis - Comparison between2021 and 2026

4.2 Bargaining power of buyers

Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers

Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants

Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes

Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry

Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition

Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments

Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)

5.2 Comparison by Product

Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product

5.3 OTC pharmaceuticals - Market size and forecast 2021-2026

Exhibit 28: Chart on OTC pharmaceuticals - Market size and forecast 2021-2026 ($ billion)
Exhibit 29: Data Table on OTC pharmaceuticals - Market size and forecast 2021-2026 ($ billion)
Exhibit 30: Chart on OTC pharmaceuticals - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on OTC pharmaceuticals - Year-over-year growth 2021-2026 (%)

5.4 Dietary supplements - Market size and forecast 2021-2026

Exhibit 32: Chart on Dietary supplements - Market size and forecast 2021-2026 ($ billion)
Exhibit 33: Data Table on Dietary supplements - Market size and forecast 2021-2026 ($ billion)
Exhibit 34: Chart on Dietary supplements - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Dietary supplements - Year-over-year growth 2021-2026 (%)

5.5 Market opportunity by Product

Exhibit 36: Market opportunity by Product ($ billion)

6 Customer Landscape

6.1 Customer landscape overview

Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation

Exhibit 38: Chart on Market share by geography 2021-2026 (%)
Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison

Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026

Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Asia - Market size and forecast 2021-2026

Exhibit 46: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 47: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
Exhibit 48: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.5 Europe - Market size and forecast 2021-2026

Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026

Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026

Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 China - Market size and forecast 2021-2026

Exhibit 62: Chart on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 63: Data Table on China - Market size and forecast 2021-2026 ($ billion)
Exhibit 64: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on China - Year-over-year growth 2021-2026 (%)

7.9 UK - Market size and forecast 2021-2026

Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)

7.10 Germany - Market size and forecast 2021-2026

Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.11 Canada - Market size and forecast 2021-2026

Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

7.12 Market opportunity by geography

Exhibit 78: Market opportunity by geography ($ billion)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges

Exhibit 79: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape

Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption

Exhibit 81: Overview on factors of disruption

9.4 Industry risks

Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered

Exhibit 83: Vendors covered

10.2 Market positioning of vendors

Exhibit 84: Matrix on vendor position and classification

10.3 Abbott Laboratories

Exhibit 85: Abbott Laboratories - Overview
Exhibit 86: Abbott Laboratories - Business segments
Exhibit 87: Abbott Laboratories - Key news
Exhibit 88: Abbott Laboratories - Key offerings
Exhibit 89: Abbott Laboratories - Segment focus

10.4 Amway Corp.

Exhibit 90: Amway Corp. - Overview
Exhibit 91: Amway Corp. - Product / Service
Exhibit 92: Amway Corp. - Key news
Exhibit 93: Amway Corp. - Key offerings

10.5 BASF SE

Exhibit 94: BASF SE - Overview
Exhibit 95: BASF SE - Business segments
Exhibit 96: BASF SE - Key news
Exhibit 97: BASF SE - Key offerings
Exhibit 98: BASF SE - Segment focus

10.6 Bayer AG

Exhibit 99: Bayer AG - Overview
Exhibit 100: Bayer AG - Business segments
Exhibit 101: Bayer AG - Key offerings
Exhibit 102: Bayer AG - Segment focus

10.7 BioGaia AB

Exhibit 103: BioGaia AB - Overview
Exhibit 104: BioGaia AB - Product / Service
Exhibit 105: BioGaia AB - Key news
Exhibit 106: BioGaia AB - Key offerings

10.8 Boehringer Ingelheim International GmbH

Exhibit 107: Boehringer Ingelheim International GmbH - Overview
Exhibit 108: Boehringer Ingelheim International GmbH - Business segments
Exhibit 109: Boehringer Ingelheim International GmbH - Key news
Exhibit 110: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 111: Boehringer Ingelheim International GmbH - Segment focus

10.9 GlaxoSmithKline Plc

Exhibit 112: GlaxoSmithKline Plc - Overview
Exhibit 113: GlaxoSmithKline Plc - Business segments
Exhibit 114: GlaxoSmithKline Plc - Key news
Exhibit 115: GlaxoSmithKline Plc - Key offerings
Exhibit 116: GlaxoSmithKline Plc - Segment focus

10.10 Johnson and Johnson

Exhibit 117: Johnson and Johnson - Overview
Exhibit 118: Johnson and Johnson - Business segments
Exhibit 119: Johnson and Johnson - Key news
Exhibit 120: Johnson and Johnson - Key offerings
Exhibit 121: Johnson and Johnson - Segment focus

10.11 Pfizer Inc.

Exhibit 122: Pfizer Inc. - Overview
Exhibit 123: Pfizer Inc. - Product / Service
Exhibit 124: Pfizer Inc. - Key news
Exhibit 125: Pfizer Inc. - Key offerings

10.12 Sanofi

Exhibit 126: Sanofi - Overview
Exhibit 127: Sanofi - Business segments
Exhibit 128: Sanofi - Key news
Exhibit 129: Sanofi - Key offerings
Exhibit 130: Sanofi - Segment focus

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist

Exhibit 131: Inclusions checklist
Exhibit 132: Exclusions checklist

11.3 Currency conversion rates for US$

Exhibit 133: Currency conversion rates for US$

11.4 Research methodology

Exhibit 134: Research methodology
Exhibit 135: Validation techniques employed for market sizing
Exhibit 136: Information sources

11.5 List of abbreviations

Exhibit 137: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio